Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) Invested Capital: 2009-2024

Historic Invested Capital for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to $1.4 billion.

  • Pediatrix Medical's Invested Capital fell 355.2% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 355.2%. This contributed to the annual value of $1.4 billion for FY2024, which is 646.54% down from last year.
  • Per Pediatrix Medical's latest filing, its Invested Capital stood at $1.4 billion for FY2024, which was down 646.54% from $1.5 billion recorded in FY2023.
  • Over the past 5 years, Pediatrix Medical's Invested Capital peaked at $2.4 billion during FY2020, and registered a low of $1.4 billion during FY2024.
  • Moreover, its 5-year median value for Invested Capital was $1.5 billion (2022), whereas its average is $1.7 billion.
  • Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 6318.16% in 2020, then plummeted by 2293.26% in 2021.
  • Over the past 5 years, Pediatrix Medical's Invested Capital (Annual) stood at $2.4 billion in 2020, then fell by 22.93% to $1.9 billion in 2021, then fell by 18.95% to $1.5 billion in 2022, then dropped by 3.77% to $1.5 billion in 2023, then fell by 6.47% to $1.4 billion in 2024.
  • Its Invested Capital stands at $1.4 billion for FY2024, versus $1.5 billion for FY2023 and $1.5 billion for FY2022.